| Role of immune-checkpoint inhibitors in lung cancer P Jain, C Jain, V Velcheti Therapeutic advances in respiratory disease 12, 1753465817750075, 2018 | 118 | 2018 |
| Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade P Vaidya, K Bera, PD Patil, A Gupta, P Jain, M Alilou, M Khorrami, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 77 | 2020 |
| Safety and efficacy of PD-1/PD-L1 inhibitors in treatment-naive and chemotherapy-refractory patients with non–small-cell lung cancer: a systematic review and meta-analysis M Khunger, P Jain, S Rakshit, V Pasupuleti, AV Hernandez, J Stevenson, ... Clinical lung cancer 19 (3), e335-e348, 2018 | 63 | 2018 |
| Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features M Khorrami, P Jain, K Bera, M Alilou, R Thawani, P Patil, U Ahmad, ... Lung Cancer 135, 1-9, 2019 | 60 | 2019 |
| Cardiovascular events associated with chimeric antigen receptor T cell therapy: cross-sectional FDA adverse events reporting system analysis A Guha, D Addison, P Jain, JM Gutierrez, A Ghosh, C Roddie, M de Lima, ... Biology of Blood and Marrow Transplantation 26 (12), 2211-2216, 2020 | 49 | 2020 |
| Collagenous colitis is associated with HLA signature and shares genetic risks with other immune-mediated diseases E Stahl, G Roda, A Dobbyn, J Hu, Z Zhang, H Westerlind, F Bonfiglio, ... Gastroenterology 159 (2), 549-561. e8, 2020 | 39 | 2020 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 31 | 2023 |
| Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study O Kaidar-Person, I Meattini, P Jain, P Bult, N Simone, I Kindts, R Steffens, ... Breast cancer research and treatment 167, 479-483, 2018 | 31 | 2018 |
| Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States P Jain, JG Bugarin, A Guha, C Jain, N Patil, T Shen, I Stanevich, V Nikore, ... ESMO open 6 (5), 100252, 2021 | 30 | 2021 |
| Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of trials. M Khunger, V Pasupuleti, S Rakshit, P Jain, PJ Mazzone, J Stevenson, ... Journal of Clinical Oncology 35 (15_suppl), e20647-e20647, 2017 | 29 | 2017 |
| Successful outcome following resection of a pancreatic liposarcoma with solitary metastasis IM Dodo, JA Adamthwaite, P Jain, A Roy, PJ Guillou, KV Menon World Journal of Gastroenterology 11 (48), 7684, 2005 | 26 | 2005 |
| MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies M Lee, P Jain, F Wang, PC Ma, A Borczuk, B Halmos Expert Opinion on Therapeutic Targets 25 (4), 249-268, 2021 | 24 | 2021 |
| Afatinib and lung cancer P Jain, R Khanal, A Sharma, F Yan, N Sharma Expert Review of Anticancer Therapy 14 (12), 1391-1406, 2014 | 22 | 2014 |
| Novel non-invasive radiomic signature on CT scans predicts response to platinum-based chemotherapy and is prognostic of overall survival in small cell lung cancer P Jain, M Khorrami, A Gupta, P Rajiah, K Bera, VS Viswanathan, P Fu, ... Frontiers in Oncology 11, 744724, 2021 | 19 | 2021 |
| Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries A Guha, P Jain, MG Fradley, D Lenihan, JM Gutierrez, C Jain, M de Lima, ... Cancer medicine 10 (12), 3862-3872, 2021 | 18 | 2021 |
| Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting G Kunapareddy, B Switzer, P Jain, M Conces, YW Chen, B Patel, S Patel, ... Research and Practice in Thrombosis and Haemostasis 3 (2), 226-233, 2019 | 14 | 2019 |
| Association between myocarditis and other immune‐related adverse events secondary to immune checkpoint inhibitor use. A Guha, S Al‐Kindi, P Jain, N Tashtish, C ElAmm, GH Oliveira International Journal of Cancer 147 (6), 2020 | 13 | 2020 |
| Teaching NeuroImages: Distinct neuroimaging features of fucosidosis P Jain, K Ramesh, A Mohamed, A Kumar, S Gulati Neurology 78 (5), e33-e33, 2012 | 12 | 2012 |
| Breast cancer with brain metastases in pregnancy. S Gupta, P Jain, S McDunn The Journal of Community and Supportive Oncology 12 (10), 378-380, 2014 | 11 | 2014 |
| Morphometrics of bees PC Jain, KS Kushwaha Apis dorsata, 38-40, 1972 | 10 | 1972 |
Vamsidhar Velcheti MD FACP FCCPYale UniversityVerified email at yale.edu
